Antimicrobial Resistance and Street Medicines in Central Africa: a One Health Approach

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202602691070782

Enrollment

400

Registered

2026-02-03

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antimicrobial resistance

Interventions

Stool collection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Adults (> 18 years old) • Written, signed, and dated informed consent

Exclusion criteria

Exclusion criteria: • Individuals presenting with acute diarrhea at the time of the study • Individuals receiving antibiotic treatment for more than 48 hours at the time of the study

Design outcomes

Primary

Measure	Time frame
To estimate the prevalence of gastrointestinal carriage of ESBL-producing Enterobacterales in humans. Single time point at enrolment/baseline (cross-sectional; one visit per participant; no follow-up).	—

Secondary

Measure	Time frame
To estimate the prevalence of gastrointestinal carriage of E carbapenemase-producing Enterobacterales in humans. Single time point at enrolment/baseline (cross-sectional; one visit per participant; no follow-up).	—

Countries

Congo

Contacts

Public ContactNicole Prisca Makaya Dangui Nieko

Professor

nicolemakaya@gmail.com+242066586533

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026